Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


Social Media in the Pharmaceutical Industry

23 Jan 2013 - 24 Jan 2013 - London, UK



Bookmark and Share


Connectivity, Engagement and Implementation

Sponsored by: greater than one

Book by 28th September and receive a £300 discount

Visit www.social-media-pharma.com to claim your discount!

SMi Group is proud to present the 5th conference in their highly successful series of Social Media in the Pharmaceutical Industry this January that will allow companies to focus on how to improve their existing social media strategies, how to innovate into the new and emerging techniques and technologies and enhancing their company’s engagement potential. We are excited to also feature talks from key companies in the industry, including Google, Pfizer, UCB Pharma and Bayer, and will focus on case studies from the industry, techniques for social media use and implementation of social media mechanisms. 

Key reasons to attend include:

Speak with the key opinion leaders of the industry about the future of social media, digital pharma, e-marketing and regulations

Hear about the case studies in the industry: how the affected those involved, how they were successful and the reasons that they were unsuccessful

Learn about crisis management, adaptations and risk management in unsuccessful campaigns, and apply them to your own company’s

Discuss the latest technologies in social media with companies that create them, and debate their benefits and difficulties with those companies that utilise them

Put forward problems and difficulties of your own, and discuss potential solutions and action plans for the future

Expert Key speakers include:

Beat Buehlmann, Industry Leader Healthcare UK, Google Inc

Trish Nettleship, Director, Social Media & Influence, UCB Pharma

 • Rahul Agrawal, Global Director, Clinical Development and Strategic 

Marketing, Bayer Healthcare

Andrew Widger, Director, Media Relations EMEA Pfizer Inc

Josep Picas, President, European Association of Healthcare IT Managers


Contact Fateja Begum on tel +44 0 207 827 6184 or email fbegum@si-online.co.uk 





Further information
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!